Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | DHFR | P00374 | 1/20 | 0.43 |
| ▸ | BCL2 | P10415 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | KMO | O15229 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8103612 | 0.93 | PPARG (0.56) | PPARGDHFRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL8096137 | 0.92 | PPARG (0.50) | PPARGLTB4R2 | |
| SCHEMBL8111121 | 0.91 | PPARG (0.49) | PPARGLTB4R2 | |
| SCHEMBL8109337 | 0.91 | PPARG (0.47) | PPARGDHFRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL8111214 | 0.90 | PPARG (0.49) | PPARGDHFRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL8109452 | 0.89 | PPARG (0.48) | PPARGDHFRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL8103581 | 0.89 | PPARG (0.46) | PPARGDHFRBCL2NPC1RAB9A | |
| SCHEMBL8109451 | 0.89 | PPARG (0.48) | PPARGDHFRNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL8109434 | 0.89 | PPARG (0.49) | PPARGLTB4R2 | |
| SCHEMBL8096033 | 0.89 | PPARG (0.54) | PPARGLTB4R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-3098772-B2 | — | — | 2000-10-16 | — | — | JP | claimed |
| EP-0527851-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1993-02-24 | — | — | EP | claimed |
| WO-1991017148-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-11-14 | — | — | WO | claimed |
| EP-0527851-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1993-02-24 | — | — | EP | disclosed |
| US-5098920-A | Hypotensive agents and treatment of congestive heart failure | G. D. SEARLE & CO. (US) | 1992-03-24 | — | — | US | disclosed |
| WO-1991017148-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-11-14 | — | — | WO | disclosed |